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Accepted 20 November 2009AbstractObjective: To investigate the relationship between Helicobacter pylori infection and hyperemesis gravidarum (HG) during early pregnancy by
using serologic and stool antigen tests in developing South Anatolia region of Turkey.
Materials and Methods: A prospective cross-sectional study was performed on 40 pregnant women with HG and 40 asymptomatic controls
without gastric problems at 7e12 weeks of gestation. The sociodemographic characteristics were recorded. The presence of H pylori was
analyzed in the sera of the study-group patients by serology-specific IgG test in serum and by a stool antigen test in fecal samples.
Results: The rates of serology-specific H pylori IgG positivity were 80% (32 of 40) in patients with HG and 35% (14 of 40) in control group. The
difference between the two groups was significant [odds ratio: 6.9 (confidence interval: 2.2e22.1); p< 0.01]. The rates of H pylori stool antigen
test positivity were 87.5% (35 of 40) in patients with HG and 62.5% (25 of 40) in control groups. The difference between the two groups was
significant (odds ratio: 4.5, confidence interval: 1.09e18.5); p¼ 0.028.
Conclusion: Both serology-specific IgG and stool antigen tests seem to be good screening methods to identify H pylori in our pregnant patient
population with HG during early pregnancy.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Nausea and vomiting affect up to 50% of pregnant women
and diminish women’s quality of life and social functions in
early pregnancy [1]. In most women, these symptoms resolve
by fluid and vitamin supplementation as well as dietary
modifications. Hyperemesis gravidarum (HG) affects approx-
imately 1% of pregnancies and causes severe and protracted
vomiting that often results in dehydration, ketosis, and weight
loss [1e3].* Corresponding author. Anatolia Advanced Level Ultrasonography Center,
Cinnah Street No: 50/4 06690, Cankaya, Ankara, Turkey.
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1028-4559/$ - see front matter Copyright  2011, Taiwan Association of Obstetri
doi:10.1016/j.tjog.2009.11.003The onset of HG is always in the first trimester. The cause
of HG, which still remains unknown, seems to be multifac-
torial and may be the end result of various unrelated condi-
tions [3,4]. There is evidence indicating that, in HG, there are
endocrine factors, such as elevated human chorionic gonado-
tropine, estradiol, and steroid hormone levels; gastrointestinal
tract dysfunction; psychological causes; anatomical variations;
genetic incompatibility; immunological factors; vitamin B6;
and trace-element deficiency [2e4].
Helicobacter pylori is a spiral-shaped, gram-negative
bacterium that is found in the gastric mucous layer or is
adherent to the epithelial lining of the stomach. Most people
who are infected by H pylori never suffer any symptoms
related to the infection; however, H pylori is associated with
chronic gastritis, gastroduodenal ulcers, duodenal structural
and functional abnormalities, and gastric malignancies [5].cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Sociodemographic characteristics of the study and control groups
Sociodemographic
characteristics
Hyperemesis (n¼ 40) Control (n¼ 40) p
Age (yr) 25.8 4.72 28.4 4.21 0.025
Gravidity 1.9 1.2 2.2 1.2 0.14
Parity 0.5 0.7 0.7 0.9 0.17
Gestational age (wk) 10.2 1.7 10.4 1.7 0.84
Body mass index (kg/m2) 23.8 3.88 25.6 3.54 0.066
Education 8 yr 21 (52.5) 18 (45) 0.22
Worker/student 4 (10) 6 (15) 0.28
Family income
(TL/month)
648 329 873 956 0.16
Smoking 10 (25) 5 (12.5) 0.03
Data are presented as mean standard deviation or n (%).
1 TL¼ $0.66 and e0.46.
t test and ManneWhitney U test were used for comparison.
TL¼Turkish Lira.
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pregnancy has been reported. Although there is an alteration
for H pylori prevalence between different communities and
considerable heterogeneity among studies, significant positive
association between HG and H pylori infection has been
demonstrated by a systematic review [2,6]. Indeed, endoscopic
biopsy findings demonstrate that the severity of gastrointes-
tinal symptoms in early pregnancy may be associated with the
density of H pylori infection [7].
There is an increasing importance of treatment of H. pylori
and a great need for simple, accurate, inexpensive, and
noninvasive diagnostic methods. Serologic and stool antigen
tests are the fast noninvasive techniques that should be rec-
ommended in the initial diagnosis of H pylori infection.
Serologic tests are based on the detection of specific
antieH pylori IgG antibodies in the patients’ sera. These tests
are not able to distinguish between active infection and
a previous exposure to H pylori. Different commercial kits
also have different levels of diagnostic accuracy (range,
68e82%) [8]. Stool antigen test is an enzyme immunoassay
that detects the active presence of H pylori antigen in human
feces. Stool test can be recommended for initial diagnosis in
untreated patients with a pretreatment sensitivity and speci-
ficity of 63e100% [9].
The purpose of this study was to assess the clinical utility of
noninvasive serologic and stool antigen tests for determining
H pylori prevalence in patients with HG and to determine
whether H pylori infection itself might contribute to hyper-
emesis during early pregnancy.
Materials and methods
A prospective cross-sectional study was designed and
performed between January 2004 and June 2006 at Kahra-
manmaras Sutcu Imam University Hospital, Department of
Obstetrics and Gynecology, in a developing South Anatolia
region of Turkey. Institutional review board had approved the
study. Forty women who were hospitalized with the diagnosis
of HG and 40 healthy pregnant women without any gastro-
intestinal symptoms, attending the antenatal unit of the
university, were included in the study. In total, 80 pregnant
women with gestational age between 7e12 weeks confirmed
by ultrasonographic measurement were recruited.
Severe nausea and vomiting in the first trimester with
a frequency of more than three times per day, weight loss
greater than 5% of pre-pregnancy weight, ketonuria and
dehydration that require hospital admission, and intravenous
fluid therapy were the criteria for the diagnosis of HG. The
exclusion criteria of the study participants were uncertain
gestational age; multiple pregnancy; urinary tract infections;
previous treatment with H pylori eradication therapy; and
endocrine, hepatic, gastrointestinal, and psychological disor-
ders. Controls were those who had singleton uncomplicated
pregnancies without HG symptoms.
After obtaining informed consent, sociodemographic data,
such as educational level, working status, monthly family
income, were recorded by a detailed questionnaire at firsttrimester. Maternal blood collected by venipuncture and stool
samples from each patient were collected in clean cups. Blood
samples were taken from 80 patients between 7 weeks and 12
weeks of gestation (study and control groups) and were kept at
room temperature for 30 minutes till they coagulated. Then,
they were centrifuged at 3,000 rpm for 10 minutes, and serums
were obtained. These serum samples were stored at 20C
until studied. Helicobacter pylori IgG antibodies were inves-
tigated by enzyme-linked immunosorbent assay (ELISA) kit
(Euroimmun Lu¨beck, Germany). Serum specimens were
analyzed as described by the kit procedure. Adsorbance was
read at 450 nm by the threshold value of optic density. A
threshold value greater than or equal to 20% was interpreted as
a positive result, and a value less than 20% was interpreted as
a negative result.
Helicobacter pylori antigens were investigated by ELISA
(Connex GmbH, Martinsried, Germany) method in stool
specimens that were stored at 80C. The results were
analyzed spectrophotometrically. Absorbance was read at
450/650 nm within 15 minutes of adding stop solution. The
results were considered positive if the OD was greater than
0.12 and negative if it was less than 0.10.
Data were stored and analyzed using SPSS 11.0 statistical
package (SPSS Inc., Chicago, IL, USA) and expressed as
mean standard deviation or n (%). Demographic findings and
clinical measures were compared with ManneWhitney U test
and t test. Comparison of serologic results for H pylori IgG
antibody and stool antigen were assessed by Chi-square test. A
p value less than 0.05 was considered statistically significant.Results
A total of 80 patients were enrolled into the study. The
sociodemographic data of these are presented in Table 1.
There were no significant differences in gravidity, parity, body
mass index, educationaleworking status, and family income,
in women with HG and the controls. The maternal charac-
teristics of age and smoking were associated with hyperemesis
(Table 1). The mean age was 25.8 years in the study group and
Table 2
Positivity rates for Helicobacter pyloriespecific IgG and stool antigen in hyperemesis and control cases
Helicobacter pylori tests Hyperemesis (n¼ 40) Control (n¼ 40) p Odds ratio (95%
confidence interval)
Helicobacter pylori IgG 32 (80) 14 (35) <0.001 6.9 (2.2e22.1)
Helicobacter pylori stool antigen 35 (87.5) 25 (62.5) 0.028 4.5 (1.09e18.5)
Data are presented as n (%).
Chi-square test was performed.
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percent (10 of 40) among patients with HG and 12.5% (5 of
40) among control group were smokers ( p¼ 0.02).
In the HG study group, 52.5% women had less than or
equal to 8 years of school education; 4% women were
workers/students; and approximately 56% of mothers had
given birth to their first childdonly 6% of the mothers had
a parity of at least three, 18% had a body mass index less than
20 kg/m2 at the beginning of pregnancy, and 5% had a body
mass index greater than 30 kg/m2.
The rates of serologic H pyloriespecific IgG positivity
were 80% (32 of 40) in patients with HG and 35% (14 of 40)
in control group. The difference between the two groups was
significant [odds ratio (OR): 6.9, confidence interval (CI):
2.2e22.1; p< 0.01]. The rates of H pylori stool antigen test
positivity were 87.5% (35 of 40) among patients with HG and
62.5% (25 of 40) in control group. The difference between the
two groups was significant [OR: 4.5, CI: 1.09e18.5;
p¼ 0.028] (Table 2). The Anatolia regions in Turkey and also
the countries of the Europe/Middle East adjacent to Turkey are
shown in the map in Fig. 1.
Discussion
The pathophysiology of HG is still controversial. However,
pregnancy may be associated with an increased susceptibility
to H pylori infection [6], and it has been hypotheticallyFig. 1. The regions/cities in Turkey and countriesproposed that a shift in gastrointestinal tract pH during early
pregnancy as a result of increased accumulation of woman’s
body fluid, steroid hormone changes, and immunologic
tolerance, could lead the activation of latent H pylori infec-
tion, which can exaggerate the symptoms of nausea and
vomiting [10]. In one controlled trial, endoscopic biopsy
findings demonstrated that the severity of gastrointestinal
symptoms in early pregnancy may be associated with the
density of H pylori infection [7]. Shirin et al [11] reported
recently that H pylori is associated with mild vomiting in early
pregnancy but not with gastrointestinal symptoms later in
pregnancy.
In earlier studies, detection of H pylori prevalences in
patients with HG and the controls was performed by whole-
blood or serum-based serologic tests, which show chronic
infection. The main differences between our study and the
previous studies are that we evaluated the association between
H pylori and HG by both serologic and stool antigen tests and
compared the clinical utilities of these noninvasive tests in
early pregnancy. Also, this is the first study that was performed
in the developing South Anatolia region of Turkey. The
present findings support the possible relationship between
H pylori and HG, and also suggest that there is an inverse
correlation between socioeconomic status and prevalence rate
of H pylori in developing areas.
A recent geographically stratified multinational European
study performed by serology demonstrated that the overallof the Europe/Middle East adjacent to Turkey.
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significantly higher both in patients with HG and the controls
(Yugoslavia: 96.4%; Austria: 83.3%; Poland: 84.6%; Turkish
pregnant woman: 93.3%; and Arab countries: 86.7%) [12].
Two studies that were performed in different regions of Iran’s
pregnant population demonstrated statistically significant high
and different H pylori seropositivity rates in HG cases (81.5%
vs. 54.7% and 88.9% vs. 40.7%) [13,14]. In Chinese patients
with HG, a prevalence rate of 88.9% for H pylori has been
shown [15]. The overall prevalence of H pylori seropositivity
rates in Israel [11], Japan [16], Norway [17], and Hispanic
population [18] affected by HG are 45.9%, 47.5%, 43%, and
66% respectively. A study from Taiwan demonstrated a sero-
positivity rate of 69% in pregnant women with severe
gastrointestinal symptoms during early pregnancy; however,
no correlation was found between seropositivity and clinical
symptoms [19]. Race affect the presence of H pylori, and this
association was much stronger in Africans as compared with
non-Africans [17]. First of all, the results of these studies give
some clues about the effect of geography, economy, race, and
country origin on H pylori prevalence.
Additionally, another similar study that was performed in
developing North Anatolia region detected 91.5% seroposi-
tivity in patients with HG as compared with 44.8% in the
controls [10]. The studies that were carried out in Iran and
Turkey are along the same line as our study, but we detected
a seropositivity ratio of 80% in the HG group and 36.7% in the
control group; the difference between the two groups was
significant [OR: 6.9, CI: 2.2e22.1; p< 0.001]. On the other
hand, Jacobson et al [20] found no relationship between
HG and H pylori by the serologic test in two American pop-
ulations but showed the association among the risk of HG,
young maternal age, and African American race. In this study,
subjects and controls were not matched for maternal age.
Another study that was performed in Central Anatolia region
of Turkey could not demonstrate an association between
H pylori seropositivity and HG [21]. Although, in this study, it
was mentioned that all the study participants were from areas
of low socioeconomic status, this situation was designated
only by the education level.
To date, there are two studies in the literature evaluating the
association between H pylori and HG by two noninvasive tests.
These two studies were carried out in developed Western and
Central Anatolia regions of Turkey [22,23]. Cevrioglu et al [22]
reported that the frequencies of H pylori detection by serologic
H pylori IgG and by stool antigen tests were about 2.1 and 5
times higher, respectively, in cases with HG than those in
asymptomatic cases. The weak point of that study was the low
number of cases (n¼ 27), and also, in that study, the education
level affecting the H pylori prevalence was higher than that in
our study population. Karadeniz et al [23] found no association
betweenHpylori andHGby specific serologic and stool antigen
tests. Another study that was performed in Central Anatolia
region by Aytac et al [24] detected 42.3%H pylori stool antigen
positivity in patients with HG as compared with 40% of
controls. Our results are not in concordance with these studies;
we found that H pylori detection was about seven times higherby serologic test and was 4.5 times higher by stool antigen test
in cases with HG than those in controls. The prevalence of
H pylori in our region was 87.5% by stool antigen test, which
indicates active infection in HG cases, and this rate is higher
than those in other studies. In all these studies, the socioeco-
nomic status, such as income level, working status, has not been
analyzed in detail. Moreover, the discrepancy between these
studies and our study may be explained by multiple factors,
such as geographic discriminations between regions of Turkey,
as well as a population difference or a difference in method-
ology of socioeconomic level.
Moreover, we found that young maternal age and smoking
were associated with increased risk of HG and H pylori. These
findings are along the same line as previous studies [25,26].
Low socioeconomic level is a major risk factor for H pylori
acquisition [27]. Although not statistically significant, in our
study, there is a tendency of occurrence of HG and infection
with H pylori in patients with lower socioeconomic level. In
addition, there is a high prevalence rate of H pylori by stool
antigen test, which shows active infection in our control group.
This might be the result of low socioeconomic level of our
study population or pregnant women’s tendency to carry
H Pylori infection.
In the light of these findings, our study provides new data
that regional and geographic differences, and populations’
sociodemographic variations affect the H pylori prevalence
rates. Moreover, we suggest that H pylori diagnostic serologic
and stool antigen tests could be a part of HG investigation
during early pregnancy, especially in cases showing resistant
or no response to treatment.References
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